Daniel Gusenleitner Selected Research

Ligands

11/2017	Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma.
11/2016	An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Gusenleitner Research Topics

Disease

13	Neoplasms (Cancer) 01/2024 - 02/2011
10	Melanoma (Melanoma, Malignant) 01/2024 - 01/2018
2	Breast Neoplasms (Breast Cancer) 11/2016 - 06/2015
1	Mesothelioma 01/2024
1	Triple Negative Breast Neoplasms 01/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2024
1	Inflammation (Inflammations) 01/2022
1	Hodgkin Disease (Hodgkin's Disease) 11/2017
1	Neoplasm Metastasis (Metastasis) 11/2016

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2018
4	spartalizumabIBA 01/2024 - 10/2020
4	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2018
4	dabrafenibIBA 01/2022 - 01/2020
4	trametinibIBA 01/2022 - 01/2020
3	Programmed Cell Death 1 ReceptorIBA 01/2023 - 11/2017
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2018
2	Interleukin-17 (Interleukin 17)IBA 09/2023 - 01/2023
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2011
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 10/2020
2	LigandsIBA 11/2017 - 11/2016
1	InterleukinsIBA 01/2023
1	CytokinesIBA 01/2023
1	Circulating Tumor DNAIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Ligases (Synthetase)IBA 01/2018
1	InterferonsIBA 01/2018
1	HLA-A Antigens (HLA-A)IBA 01/2018
1	HLA-B Antigens (HLA-B)IBA 01/2018
1	HLA-C Antigens (HLA-C)IBA 01/2018
1	AntigensIBA 01/2018
1	UbiquitinIBA 01/2018
1	CTLA-4 AntigenIBA 01/2018
1	KynurenineIBA 11/2016
1	xanthurenic acidIBA 11/2016
1	Tryptophan (L-Tryptophan)FDA Link 11/2016
1	EnzymesIBA 11/2016
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2016
1	Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)IBA 11/2016
1	6- (1H- indazol- 6- yl)- N- (4- morpholinophenyl)imidazo(1,2- a)pyrazin- 8- amineIBA 01/2016
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 01/2016
1	Syk KinaseIBA 01/2016
1	CarcinogensIBA 06/2015
1	ParaffinIBA 01/2015
1	Formaldehyde (Formol)FDA Link 01/2015

Therapy/Procedure

7	Therapeutics 01/2024 - 01/2018
1	Immunotherapy 01/2018